Zobrazeno 1 - 10
of 28
pro vyhledávání: '"John B. March"'
Publikováno v:
BioTechniques, Vol 29, Iss 3, Pp 536-542 (2000)
The stability of restriction enzymes as supplied by manufacturers without any modification has been examined. No reduction in activity was observed for three enzymes (HindIII, EcoRI and Tsp509I) held at ambient temperature or 4°C for the period of s
Externí odkaz:
https://doaj.org/article/77a398f11ef64b61b42ab025dae1513b
Publikováno v:
Veterinary Immunology and Immunopathology. 144:389-395
A bacteriophage-delivered DNA vaccine against Chlamydophila abortus was constructed by cloning a eukaryotic cassette containing the ompA gene (which expresses the Major Outer Membrane Protein) into a bacteriophage lambda vector. Four groups, each of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2661d5e0705184fd3e8c7b287bc10ce
https://doi.org/10.1016/j.vetimm.2011.08.003
https://doi.org/10.1016/j.vetimm.2011.08.003
Publikováno v:
FEMS Immunology & Medical Microbiology. 61:197-204
A bacteriophage lambda DNA vaccine expressing the small surface antigen (HBsAg) of hepatitis B was compared with Engerix B, a commercially available vaccine based on the homologous recombinant protein (r-HBsAg). Rabbits (five per group) were vaccinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43bc35c515bc474ab15d4cc04f21e10b
https://doi.org/10.1111/j.1574-695x.2010.00763.x
https://doi.org/10.1111/j.1574-695x.2010.00763.x
Autor:
John B. March
Publikováno v:
Expert Review of Vaccines. 5:753-759
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e07950734856d9d685975ca045b39e9
https://doi.org/10.1586/14760584.5.6.753
https://doi.org/10.1586/14760584.5.6.753
Autor:
Jason R. Clark, John B. March
Publikováno v:
Trends in Biotechnology. 24:212-218
In recent years it has been recognized that bacteriophages have several potential applications in the modern biotechnology industry: they have been proposed as delivery vehicles for protein and DNA vaccines; as gene therapy delivery vehicles; as alte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d6277f52e04245bfe255e046f889e45
https://doi.org/10.1016/j.tibtech.2006.03.003
https://doi.org/10.1016/j.tibtech.2006.03.003
Publikováno v:
Infection and Immunity. 74:167-174
A new strategy for rapidly selecting and testing genetic vaccines has been developed, in which a whole genome library is cloned into a bacteriophage λ ZAP Express vector which contains both prokaryotic (P lac ) and eukaryotic (P CMV ) promoters upst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e921dd01850263e88ef8d653ae8920cd
https://doi.org/10.1128/iai.74.1.167-174.2006
https://doi.org/10.1128/iai.74.1.167-174.2006
Autor:
John B. March
Publikováno v:
Vaccine. 22:4358-4364
Contagious bovine pleuropneumonia (CBPP) is an economically important transboundary disease, widely present in sub-saharan Africa. Social, cultural and economic factors mean that effective vaccination is the only viable control policy at present. Unf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022623bb46613d8f849e1b60a5815f29
https://doi.org/10.1016/j.vaccine.2004.03.066
https://doi.org/10.1016/j.vaccine.2004.03.066
Autor:
Jason R. Clark, John B. March
Publikováno v:
Expert Review of Vaccines. 3:463-476
Bacteriophages (or phages) are viruses of bacteria, consisting of nucleic acid packaged within a protein coat. In eukaryotic hosts, phages are unable to replicate and in the absence of a suitable prokaryotic host, behave as inert particulate antigens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca4963bb26e9fd0c2bb94e107337cf43
https://doi.org/10.1586/14760584.3.4.463
https://doi.org/10.1586/14760584.3.4.463
Publikováno v:
Vaccine. 22:1666-1671
Mice and rabbits have been vaccinated with whole bacteriophage lambda particles containing a DNA vaccine expression cassette under the control of the CMV promoter (enhanced green fluorescent protein [lambda-EGFP] or hepatitis B surface antigen [lambd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fc792531bc8a05ddd57efda3d6fca32
https://doi.org/10.1016/j.vaccine.2003.10.047
https://doi.org/10.1016/j.vaccine.2003.10.047
Autor:
John B. March
Publikováno v:
Expert Review of Vaccines. 3:113-117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0fbc333b2d7d7f38e2792ad9119942b
https://doi.org/10.1586/14760584.3.2.113
https://doi.org/10.1586/14760584.3.2.113